The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics

Iftikhar Haider Naqvi; Abu Talib; Khalid Mahmood; Rida Abidi; Saiyeda Nayema Zehra Rizvi

doi:10.5114/pg.2019.83872

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2019
vol. 14

Send email

Copy url:

abstract:

Original paper

The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics

Iftikhar Haider Naqvi

¹

,

Abu Talib

¹

,

Khalid Mahmood

¹

,

Rida Abidi

¹

,

Saiyeda Nayema Zehra Rizvi

²

Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan
Florence Medical Centre, Karachi, Pakistan

Gastroenterology Rev 2019; 14 (4): 250–257

DOI: https://doi.org/10.5114/pg.2019.83872

Online publish date: 2019/03/25

View full text Get citation

PlumX metrics:

Introduction
Albumin-bilirubin (ALBI) is a newly devised scoring system for prognostication of liver cirrhosis. The ALBI has recently been validated and found superior to Child-Turcotte-Pugh score (CTP) and Model for End stage Liver Disease (MELD) in assessing severity of liver disease.

Aim
To determine the ALBI score’s mortality prediction among cirrhotics, associated complications and to compare its prognostic proficiency to that of MELD and CTP.

Material and methods
The diagnostic accuracy of CTP, MELD and ALBI scores for mortality in hospitalized cirrhotic patients was determined by receiver operating characteristic curve (ROC) analysis. The areas under the ROC curve were calculated, with confidence intervals (CI) of 95%. The best cut-off values were ascertained with the greatest specificity and sensitivity.

Results
The study showed overall in-hospital mortality of 25.5%. Median CTP score was 10.2 (IQR = 3) and area under curve (AUC) was 0.842 (95% CI: 0.817–0.868, p < 0.001) with sensitivity of 75.0% and specificity of 79.2%. Median MELD score was 20.9 (IQR = 7.2) and AUC was 0.836 (95% CI: 0.810–0.863, p < 0.001) with sensitivity of 76.6% and specificity of 76.7%. Median ALBI score was –1.1 (IQR = 1.0), and AUC of ALBI was 0.852 (95% CI: 0.826–0.879, p < 0.001) with sensitivity and specificity of 78.1%.

Conclusions
The objective prognostication and easy utilization of ALBI make it a useful alternative to MELD and CTP and therefore favour its applicability in clinical practice. Further validations in large prospective cohorts are needed for prognostic value of ALBI in cirrhosis and its complications.

keywords:

The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics

Iftikhar Haider Naqvi 1 , Abu Talib 1 , Khalid Mahmood 1 , Rida Abidi 1 , Saiyeda Nayema Zehra Rizvi 2

Child-Turcotte-Pugh score, Model for End stage Liver Disease, albumin-bilirubin

Iftikhar Haider Naqvi

¹

,

Abu Talib

¹

,

Khalid Mahmood

¹

,

Rida Abidi

¹

,

Saiyeda Nayema Zehra Rizvi

²